About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Atlanta | 13,019 Studies Near You

Clinical TrialsAtlanta

Clinical Trials in Atlanta

Discover 13,019 clinical trials near Atlanta, Georgia. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2881-2900 of 13,019 trials

CompletedA Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test IntervalThis is a prospective longitudinal study to assess the impact of repeat Cologuard testing at 3 years in average risk patients.NCT02419716·Glendale, Arizona and 39 others

Find Trials by Condition in Atlanta

Breast Cancerin Atlanta Lung Cancerin Atlanta Prostate Cancerin Atlanta Colorectal Cancerin Atlanta Melanomain Atlanta Leukemiain Atlanta Lymphomain Atlanta Pancreatic Cancerin Atlanta Ovarian Cancerin Atlanta Brain Cancerin Atlanta Diabetes

Data from ClinicalTrials.govTerms

CompletedMasitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic CancerThe objective of this study is to compare the efficacy and safety of masitinib in combination with gemcitabine to placebo in combination with gemcitabine in patients with…NCT00789633·Norwich, Connecticut and 67 others

CompletedPediatric Epilepsy StudyThis study will evaluate the safety and effectiveness of oxcarbazepine (Trileptal) as monotherapy in the treatment of partial seizures in pediatric patients 1 month to 3 years of…NCT00050947·Birmingham, Alabama and 29 others

CompletedStudy to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected AdultsThe primary objective of this study is to evaluate the efficacy of switching to a fixed-dose combination (FDC) of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) versus…NCT02603107·Phoenix, Arizona and 118 others

CompletedEffects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study ParticipantsThe purpose of this study is to compare the effects of two different anti-HIV drug regimens on quality of life and health care utilization among SMART study participants.NCT00385632·Fresno, California and 66 others

CompletedClosure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval StudyThe AMPLATZER Muscular VSD Occluder was approved by the US Food and Drug Administration (FDA) in September, 2007.NCT00647387·Phoenix, Arizona and 50 others

WithdrawnInflammation, Stress & Social Behavior: Using Ecological Assessments & Model Systems to Enhance Relevance to Health OutcomesThe current study has been designed to identify behavioral and physiological mechanisms through which positive social connectivity (PCS) and negative social processes (NSP)…NCT01625793·Tucson, Arizona and 1 other

CompletedDefining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative ProcessesThe purpose of this study is to determine the potential for a Parkinson's Disease (PD) -specific breath signature as a non-invasive screening tool for identifying PD patients with…NCT02749214·Atlanta, Georgia

WithdrawnA Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor MalignanciesThe purpose of the study is to test the safety of an experimental drug called OSI-906 when combined with pemetrexed at different dose levels and to find out the optimal doses of…NCT01567384·Atlanta, Georgia

CompletedThe Altis® Single Incision Sling System for Female Stress Urinary Incontinence StudyAn international, multi-center, single arm, prospective clinical study designed to assess the safety and efficacy of the Coloplast Altis single incision sling system for females…NCT01272284·Murrieta, California and 16 others

TerminatedA Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)The main purpose of the study is to evaluate the efficacy and safety of the study drug known as prasugrel for the reduction of Vaso-Occlusive Crisis events in pediatric…NCT01794000·Oakland, California and 49 others

CompletedA Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)This is a randomized, placebo-controlled, double blind phase 2 study designed to compare treatment with ARQ 197 plus erlotinib to erlotinib plus placebo in patients with non-small…NCT00777309·Burbank, California and 37 others

CompletedRobotically Augmented Mental PracticeThis project will develop and test a new paradigm of motor imagery for facilitating neuromotor excitability and performance of distal muscles in the upper limb by adopting a…NCT04962698·Atlanta, Georgia

CompletedImmunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00070187·Birmingham, Alabama and 62 others

Completed28 Day Repeat Dose in Cystic Fibrosis PatientsThe purpose of this study is to determine whether the safety, tolerability and pharmacodynamics of SB656933 in patients that have cystic fibrosisNCT00903201·Birmingham, Alabama and 32 others

Active not recruitingShort-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food AllergyThis study is researching an experimental drug called linvoseltamab combined with another drug called dupilumab.NCT06369467·Tampa, Florida and 4 others

Active not recruitingVK2735 for Weight Management Phase 3This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety…NCT07104500·Birmingham, Alabama and 136 others

CompletedLosartan for Patients With COVID-19 Requiring HospitalizationThis is a multi-center, double-blinded study of COVID-19 infected patients requiring inpatient hospital admission randomized 1:1 to daily Losartan or placebo for 7 days or…NCT04312009·Gainesville, Florida and 12 others

Active not recruitingIDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal MelanomaThis is a Phase 2/3, multi-arm, multi-stage, open-label study of human leukocyte antigen (HLA)-A\*02:01 negative participants with metastatic uveal melanoma (MUM) who will be…NCT05987332·Scottsdale, Arizona and 67 others

CompletedHybrid Revascularization Observational StudyThe purpose of the study is to get a better understanding of patients who have multi-vessel coronary artery disease (blockages in more than one vessel bringing blood to the heart)…NCT01121263·Atlanta, Georgia and 10 others

PreviousPage 145 of 651Next

in Atlanta

Heart Diseasein Atlanta